UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (324) 324
life sciences & biomedicine (308) 308
humans (303) 303
gastroenterology & hepatology (224) 224
male (191) 191
female (183) 183
middle aged (161) 161
adult (130) 130
antiviral agents - therapeutic use (102) 102
hepatitis c (94) 94
aged (92) 92
gastroenterology and hepatology (90) 90
hepatitis c virus (85) 85
hepatitis c, chronic - drug therapy (77) 77
hepacivirus - genetics (70) 70
genotype (63) 63
liver (63) 63
cirrhosis (62) 62
liver diseases (59) 59
treatment outcome (58) 58
interferon-alpha - therapeutic use (56) 56
care and treatment (54) 54
drug therapy, combination (54) 54
hepatitis (53) 53
risk factors (52) 52
liver cirrhosis (50) 50
liver - pathology (47) 47
fibrosis (46) 46
interferon (45) 45
abridged index medicus (41) 41
hepatitis c, chronic - virology (41) 41
hepatology (41) 41
ribavirin - therapeutic use (40) 40
analysis (37) 37
hepatocellular carcinoma (37) 37
biopsy (35) 35
patients (35) 35
recombinant proteins (35) 35
fatty liver (34) 34
italy (34) 34
health aspects (33) 33
ribavirin (32) 32
genetic aspects (31) 31
hepatitis c, chronic - complications (31) 31
antiviral agents (30) 30
antiviral agents - administration & dosage (30) 30
hcv (30) 30
hepacivirus - drug effects (30) 30
hepatitis c - drug therapy (30) 30
infectious diseases (29) 29
prospective studies (29) 29
adolescent (28) 28
liver cancer (27) 27
polyethylene glycols - therapeutic use (27) 27
biological response modifiers (25) 25
medical research (25) 25
prevalence (25) 25
antiviral agents - adverse effects (24) 24
liver cirrhosis - complications (24) 24
multivariate analysis (24) 24
cohort studies (23) 23
general & internal medicine (23) 23
medicine, general & internal (23) 23
severity of illness index (23) 23
liver cirrhosis - pathology (22) 22
ribavirin - administration & dosage (22) 22
virology (22) 22
hepatitis b (21) 21
insulin resistance (21) 21
italy - epidemiology (21) 21
liver cirrhosis - diagnosis (21) 21
liver cirrhosis - virology (21) 21
medicine (21) 21
medicine, experimental (21) 21
pharmacology & pharmacy (21) 21
viral load (21) 21
development and progression (20) 20
prognosis (20) 20
chronic disease (19) 19
chronic hepatitis (19) 19
interferon-alpha - administration & dosage (19) 19
liver cirrhosis - drug therapy (19) 19
virus diseases (19) 19
alanine transaminase - blood (18) 18
hepatitis c - complications (18) 18
liver cirrhosis - etiology (18) 18
mortality (18) 18
rna, viral - blood (18) 18
steatosis (18) 18
young adult (18) 18
digestive system diseases (17) 17
drug therapy (17) 17
hepatitis b virus - genetics (17) 17
infections (17) 17
retrospective studies (17) 17
viruses (17) 17
aged, 80 and over (16) 16
chronic hepatitis c (16) 16
genotypes (16) 16
hepacivirus - isolation & purification (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Infection, ISSN 1439-0973, 05/2018, Volume 46, Issue 5, pp. 607 - 615
... ribavirin in patients over 65 years with HCV genotype 1 cirrhosis Antonio Ascione 1 · Massimo De Luca 2 · Mario Melazzini 3 · Simona Montilla 3 · Maria Paola Trotta 3... 
Cirrhosis | Ombitasvir | Medicine & Public Health | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Paritaprevir | Elderly | Dasabuvir | Humans | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Carbamates - administration & dosage | Hepatitis C, Chronic - complications | Uracil - administration & dosage | Ribavirin - administration & dosage | Aged, 80 and over | Female | Drug Therapy, Combination | Liver Cirrhosis - etiology | Liver Cirrhosis - diagnosis | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Anilides - administration & dosage | Antiviral Agents - adverse effects | Biomarkers | Aged | Macrocyclic Compounds - administration & dosage | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Complications and side effects | Research | Hepatitis C | Drug therapy | Liver cirrhosis | Risk factors | Hypertension | Effectiveness | Liver diseases | Ritonavir | Health risks | Viruses | Pharmacology | Bilirubin | Multivariate analysis | Ribonucleic acid--RNA | Patients | Ribavirin | Hepatitis | Patient safety | Safety | Hepatitis C virus | Genotypes | Index Medicus
Journal Article
by Calvaruso, Vincenza and Cabibbo, Giuseppe and Cacciola, Irene and Petta, Salvatore and Madonia, Salvatore and Bellia, Alessandro and Tinè, Fabio and Distefano, Marco and Licata, Anna and Giannitrapani, Lydia and Prestileo, Tullio and Mazzola, Giovanni and Di Rosolini, Maria Antonietta and Larocca, Licia and Bertino, Gaetano and Digiacomo, Antonio and Benanti, Francesco and Guarneri, Luigi and Averna, Alfonso and Iacobello, Carmelo and Magro, Antonio and Scalisi, Ignazio and Cartabellotta, Fabio and Savalli, Francesca and Barbara, Marco and Davì, Antonio and Russello, Maurizio and Scifo, Gaetano and Squadrito, Giovanni and Cammà, Calogero and Raimondo, Giovanni and Craxì, Antonio and Di Marco, Vito and Craxì, A and Di Marco, V and Cammà, C and Calvaruso, V and Petta, S and Cabbibbo, G and Colletti, P and Mazzola, G and Cascio, A and Montalto, G and Licata, A and Giannitrapani, L and Prestileo, T and Di Lorenzo, F and Sanfilippo, A and Ficalora, A and Madonia, S and Tinè, F and Malizia, G and Latteri, F and Maida, M and Cartabellotta, F and Vassallo, R and Cacciola, I and Caccamo, G and Maimone, S and Saitta, C and Squadrito, G and Raimondo, G and Mondello, L and Smedile, A and D’Andrea, S and Bertino, G and Ardiri, A.L and Frazzetto, E and Rigano, G and Montineri, A and Larocca, L.N and Cacopardo, B and Benanti, F and Russello, M and Benigno, R and Bellia, A and Iacobello, C and Davì, A and Di Rosolini, M.A and Digiacomo, A and Fuduli, G and Scifo, G and Distefano, M and Portelli, V and Savalli, F and Scalici, I and Gioia, G and Magro, A and Alaimo, G and Alinovi, M.R and Salvo, A and Averna, A and Lomonaco, F and Guarneri, L and Maffeo, F and Falzone, E and Pulvirenti, F and Rete Sicilia Selezione Terapia–HCV (RESIST-HCV) and Rete Sicilia Selezione Terapia-HCV
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 08/2018, Volume 155, Issue 2, pp. 411 - 421.e4
Journal Article
Journal Article
Journal of hepatology, ISSN 0168-8278, 07/2017, Volume 67, Issue 1, pp. 65 - 71
Journal Article
PloS one, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, pp. e87523 - e87523
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 2013, Volume 19, Issue 29, pp. 5193 - 5218
Nonalcoholic fatty liver disease (NAFLD) affects about 20%-30% of the general population, and its clinical relevance arises from the fact that 20%-30% of these... 
HCV | CD36 | Steatosis | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Liver Cirrhosis - diagnosis | Algorithms | Fatty Liver - physiopathology | Humans | Non-alcoholic Fatty Liver Disease | Female | Male | Biomarkers - blood
Journal Article